Elite Athletes: Trunk Mobility, Lower Extremity Flexibility, and Functional Balance Across Sports

January 11, 2026 updated by: Burçin Uğur Tosun, Eastern Mediterranean University

Adolescent Elite Athletes: A Comparative Biomechanical Study of Trunk Mobility, Lower Extremity Flexibility, and Functional Balance Across Sports Branches

This cross-sectional observational study investigated the relationships among dynamic Q angle, core muscle endurance, hip flexibility, and lower extremity functional status in elite adolescent athletes with and without patellofemoral pain syndrome (PFPS). A total of 75 track-and-field athletes aged 15-18 years were included, 42 with PFPS and 33 healthy controls. Dynamic Q angle was assessed using a digital goniometric analysis of the step-down test, core endurance was measured with the McGill endurance tests, flexibility was evaluated using the Straight Leg Raise, Modified Thomas, and Ober tests, and functional status was assessed with the Lower Extremity Functional Scale (LEFS).

The study found that athletes with PFPS demonstrated a higher dynamic Q angle, lower core extension and lateral endurance, reduced hip flexor and iliotibial band flexibility, and lower functional scores compared with controls. Regression analyses indicated that hip flexor tightness and functional capacity were significant predictors of the dynamic Q angle in the PFPS group. These findings suggest that PFPS in adolescent athletes is a multidimensional condition influenced by proximal endurance, flexibility, and dynamic alignment rather than isolated knee-level factors.

Study Overview

Status

Completed

Detailed Description

Patellofemoral pain syndrome (PFPS) is a common overuse condition in adolescent athletes and is associated with pain, performance limitations, and reduced participation in sports activities. Increasing evidence suggests that PFPS is not limited to local knee pathology, but is influenced by proximal neuromuscular control, dynamic alignment, and soft-tissue flexibility. The dynamic Q angle, which reflects frontal-plane knee alignment during functional tasks, has been proposed as a clinically meaningful indicator of patellofemoral loading; however, the interaction between dynamic alignment, core endurance, and flexibility parameters in adolescent elite athletes remains insufficiently explored.

This cross-sectional observational study was conducted to examine the relationships among dynamic Q angle, core muscle endurance, hip and lower extremity flexibility, and functional status in elite adolescent athletes with and without PFPS. A total of 75 track-and-field athletes aged 15-18 years were included. Participants were allocated into two groups: athletes diagnosed with PFPS and healthy controls. Dynamic Q angle was assessed using digital two-dimensional video analysis of the step-down test. Core endurance was evaluated using the McGill endurance test battery (flexor, extensor, and lateral plank tests). Flexibility was assessed using the Straight Leg Raise, Modified Thomas, and Ober tests. Functional status was measured with the Lower Extremity Functional Scale (LEFS). All side-dependent measurements were analyzed on the index limb (symptomatic side in the PFPS group and matched limb in controls).

Group differences and correlations among variables were examined, and multiple regression analyses were performed to identify predictors of the dynamic Q angle. The results demonstrated that athletes with PFPS exhibited a significantly higher dynamic Q angle, reduced core extension and lateral endurance, decreased hip flexor and iliotibial band flexibility, and lower functional scores compared with controls. In the PFPS group, hip flexor tightness and functional capacity were significant predictors of the dynamic Q angle, explaining a substantial proportion of its variance.

These findings indicate that PFPS in adolescent athletes represents a multidimensional biomechanical syndrome characterized by the interaction of proximal stability, flexibility restrictions, and dynamic alignment alterations. The study highlights the clinical importance of comprehensive assessment strategies that incorporate core endurance, hip flexibility, and functional performance measures, rather than focusing solely on isolated knee-level factors. The results may contribute to the development of targeted prevention and rehabilitation strategies for adolescent athletes at risk of PFPS.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Famagusta, Cyprus, 99010
        • Burcin Ugur Tosun

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Elite adolescent track-and-field athletes training within national athletic development programs.

Description

Inclusion Criteria:

  • Elite adolescent track-and-field athletes aged 15-18 years
  • Minimum 2 years of regular training participation
  • Training at least 5 days per week
  • Ability to complete all assessment procedures
  • PFPS group: history of anterior knee pain associated with activity, positive clinical provocation tests, and AKPS score < 80
  • Control group: no history of lower extremity pain or functional limitation

Exclusion Criteria:

  • History of lower extremity surgery or acute injury within the past 6 months
  • Neurological, rheumatological, or systemic disease
  • Structural deformity of the hip, knee, or ankle
  • Ongoing orthopedic rehabilitation or regular analgesic / anti-inflammatory medication use
  • Any condition preventing participation in the tests or introducing measurement bias

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
PFPS Group/ Cohort
Adolescent elite athletes diagnosed with patellofemoral pain syndrome.
Control Group
Healthy adolescent elite athletes without anterior knee pain or lower extremity complaints.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Q Angle
Time Frame: Single assessment at baseline (cross-sectional).
Dynamic Q angle measured on the index limb during the step-down test using 2-dimensional digital goniometric video analysis. Higher values indicate greater frontal-plane malalignment.
Single assessment at baseline (cross-sectional).
Core Muscle Endurance - Extension Test
Time Frame: Single assessment at baseline.
Duration (seconds) of trunk extensor endurance test from the McGill protocol. Longer duration reflects better endurance capacity.
Single assessment at baseline.
Hip Flexor Flexibility - Modified Thomas Test
Time Frame: Baseline, single assessment.
Hip flexion angle obtained during the Modified Thomas test on the index limb. Greater angles indicate muscle tightness.
Baseline, single assessment.
Core Muscle Endurance - Lateral Plank Test
Time Frame: Single assessment at baseline.
Duration (seconds) of lateral plank endurance on the index limb according to the McGill protocol.
Single assessment at baseline.
Iliotibial Band / TFL Flexibility - Ober Test
Time Frame: Baseline, single assessment.
Adduction angle recorded during the Ober test on the index limb. Lower adduction indicates greater tightness.
Baseline, single assessment.
Hamstring Flexibility - Straight Leg Raise Test
Time Frame: Single assessment at baseline.
Hip flexion angle at the onset of pelvic compensation during passive straight leg raise. Higher angles reflect better flexibility.
Single assessment at baseline.
Functional Status - Lower Extremity Functional Scale (LEFS)
Time Frame: Baseline, single assessment.
Self-reported lower-limb functional capacity scored from 0-80, with higher scores indicating better function.
Baseline, single assessment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Actual)

September 15, 2025

Study Completion (Actual)

October 16, 2025

Study Registration Dates

First Submitted

December 25, 2025

First Submitted That Met QC Criteria

December 25, 2025

First Posted (Estimated)

January 8, 2026

Study Record Updates

Last Update Posted (Actual)

January 13, 2026

Last Update Submitted That Met QC Criteria

January 11, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Subscribe